- Home
- STRO vs NCA Comparison
STRO vs NCA Comparison
Compare STRO & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- NCA
- Stock Information
- Founded
- STRO 2003
- NCA 1987
- Country
- STRO United States
- NCA United States
- Employees
- STRO N/A
- NCA N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- NCA Investment Managers
- Sector
- STRO Health Care
- NCA Finance
- Exchange
- STRO Nasdaq
- NCA Nasdaq
- Market Cap
- STRO 172.8M
- NCA 288.4M
- IPO Year
- STRO 2018
- NCA N/A
- Fundamental
- Price
- STRO $1.93
- NCA $8.46
- Analyst Decision
- STRO Strong Buy
- NCA
- Analyst Count
- STRO 7
- NCA 0
- Target Price
- STRO $12.14
- NCA N/A
- AVG Volume (30 Days)
- STRO 1.3M
- NCA 59.6K
- Earning Date
- STRO 11-13-2024
- NCA 01-01-0001
- Dividend Yield
- STRO N/A
- NCA 3.92%
- EPS Growth
- STRO N/A
- NCA N/A
- EPS
- STRO N/A
- NCA N/A
- Revenue
- STRO $160,955,000.00
- NCA N/A
- Revenue This Year
- STRO N/A
- NCA N/A
- Revenue Next Year
- STRO N/A
- NCA N/A
- P/E Ratio
- STRO N/A
- NCA N/A
- Revenue Growth
- STRO 230.90
- NCA N/A
- 52 Week Low
- STRO $1.70
- NCA $7.77
- 52 Week High
- STRO $6.13
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- STRO 34.06
- NCA 36.66
- Support Level
- STRO $1.80
- NCA $8.30
- Resistance Level
- STRO $2.01
- NCA $8.46
- Average True Range (ATR)
- STRO 0.16
- NCA 0.11
- MACD
- STRO 0.02
- NCA -0.00
- Stochastic Oscillator
- STRO 29.49
- NCA 28.07
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.